Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism
- 1 August 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Organ Transplantation
- Vol. 16 (4), 366-371
- https://doi.org/10.1097/mot.0b013e3283484b2c
Abstract
Purpose of review The present review updates the current status of research for induction of tolerance through a mixed chimerism approach in nonhuman primates and humans. Recent findings Allograft tolerance has been successfully achieved with a nonmyeloablative conditioning regimen and donor bone marrow transplantation in human leukocyte antigen (HLA)-matched and mismatched kidney transplantation. In HLA-matched kidney transplantation, persistent mixed chimerism and renal allograft tolerance has been achieved in some patients. In HLA-mismatched combinations, induction of persistent mixed chimerism has not been achieved using a nonmyeloablative preparative regimen. Nevertheless, the transient mixed chimerism that has been achieved has resulted in long-term renal allograft tolerance in the majority of patients. Recent preclinical studies have demonstrated that the presence of heterologous memory T-cell responses observed in primates, but not in rodents, may be a major barrier for induction of durable chimerism and tolerance in primates. Strategies to overcome such memory T-cell responses may, therefore, be of great value in the development of reliable protocols for clinical tolerance induction. Summary Induction of tolerance in clinical kidney transplantation has been achieved via mixed chimerism approaches. Improvements in the consistency and safety of tolerance induction and extension of successful protocols to other organs and to organs from deceased donors will all be among the next steps in bringing tolerance to a wider range of clinical applications.Keywords
This publication has 46 references indexed in Scilit:
- Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal DiseaseTransplantation, 2011
- Selective Targeting of Human Alloresponsive CD8+ Effector Memory T Cells Based on CD2 ExpressionAmerican Journal of Transplantation, 2010
- An MHC-Defined Primate Model Reveals Significant Rejection of Bone Marrow After Mixed Chimerism Induction Despite Full MHC MatchingAmerican Journal of Transplantation, 2010
- Identification of a B cell signature associated with renal transplant tolerance in humansJCI Insight, 2010
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humansJCI Insight, 2010
- Phenotype, Distribution and Alloreactive Properties of Memory T Cells from Cynomolgus MonkeysAmerican Journal of Transplantation, 2010
- Stem Cell Mobilization and Collection for Induction of Mixed Chimerism and Renal Allograft Tolerance in Cynomolgus MonkeysJournal of Surgical Research, 2010
- Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primatesNature Medicine, 2009
- HLA-Mismatched Renal Transplantation without Maintenance ImmunosuppressionNew England Journal of Medicine, 2008
- Acquired Immune Tolerance to Cadaveric Renal AllograftsNew England Journal of Medicine, 1989